the goal of this study is to study the clinical efficacy and safety of botox in the treatment of rosacea.
The main objective is to collect patients and then use different injection volumes of botulinum toxin intradermal injection for the treatment of rosacea erythema telangiectasia, and then to evaluate the clinical efficacy and safety of the treatment.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
you are asked to return to the hospital for follow-up at weeks 2, 4, 8, and 12
Jie Dai
Nanjing, Jiangsu, China
RECRUITINGCEA score
Clinical erythema score (CEA) was divided into no, mild, moderate and severe according to the severity of rosacea, corresponding to 0,1,2,3, respectively
Time frame: 2.4,8,12 weeks
GAIS score
he Global Aesthetic Improvement Scale (GAIS) score was assessed by the treating physician on the patient's improvement and was divided into four levels: very improved corresponding, substantial improvement, improvement, no change; Corresponding to the best beauty results, significantly improved but not the best, significantly improved, no change
Time frame: 2.4,8,12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.